Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 208

1.

Primary resistance of HIV to antiretrovirals among individuals recently diagnosed at voluntary counselling and testing centres in the metropolitan region of Recife, Pernambuco.

Cavalcanti AM, Brito AM, Salustiano DM, Lima KO, Silva SP, Diaz RS, Lacerda HR.

Mem Inst Oswaldo Cruz. 2012 Jun;107(4):450-7.

PMID:
22666853
[PubMed - indexed for MEDLINE]
Free Article
2.

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.

Couto-Fernandez JC, Silva-de-Jesus C, Veloso VG, Rachid M, Gracie RS, Chequer-Fernandez SL, Oliveira SM, Arakaki-Sanchez D, Chequer PJ, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):73-8. Epub 2005 Apr 12.

PMID:
15867968
[PubMed - indexed for MEDLINE]
Free Article
3.

Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil.

Cavalcanti AM, Lacerda HR, Brito AM, Pereira S, Medeiros D, Oliveira S.

Mem Inst Oswaldo Cruz. 2007 Nov;102(7):785-92. Epub 2007 Dec 11.

PMID:
17992369
[PubMed - indexed for MEDLINE]
Free Article
4.

Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009).

Parikh UM, Kiepiela P, Ganesh S, Gomez K, Horn S, Eskay K, Kelly C, Mensch B, Gorbach P, Soto-Torres L, Ramjee G, Mellors JW; MTN-009 Protocol Team.

PLoS One. 2013 Apr 9;8(4):e59787. doi: 10.1371/journal.pone.0059787. Print 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/8096d24f-06de-4e42-8834-b5d3e116253c. IPTc Taskforce [corrected to MTN-009 Protocol Team].

PMID:
23585827
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Genotype testing and antiretroviral resistance profiles from HIV-1 patients experiencing therapeutic failure in northeast Brazil.

Medeiros MS, Arruda EA, Guerrant RL, Brown C, Hammarskjold ML, Rekosh D, Lima AA.

Braz J Infect Dis. 2007 Aug;11(4):390-4. Erratum in: Braz J Infect Dis. 2007 Oct;11(5):528-9.

PMID:
17873990
[PubMed - indexed for MEDLINE]
Free Article
6.

HIV type-1 genotypic resistance profiles in vertically infected patients from Argentina reveal an association between K103N+L100I and L74V mutations.

Aulicino PC, Rocco CA, Mecikovsky D, Bologna R, Mangano A, Sen L.

Antivir Ther. 2010;15(4):641-50. doi: 10.3851/IMP1571.

PMID:
20587857
[PubMed - indexed for MEDLINE]
7.

Testing genotypic and phenotypic resistance in human immunodeficiency virus type 1 isolates of clade B and other clades from children failing antiretroviral therapy.

Brindeiro PA, Brindeiro RM, Mortensen C, Hertogs K, De Vroey V, Rubini NP, Sion FS, De Sá CA, Machado DM, Succi RC, Tanuri A.

J Clin Microbiol. 2002 Dec;40(12):4512-9.

PMID:
12454144
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates.

García-Guerrero J, Sáiz de la Hoya P, Portilla J, Marco A, Sánchez-Payá J, Moreno S; Estudio de Resistencias en Prisiones Group.

Eur J Clin Microbiol Infect Dis. 2006 Nov;25(11):695-701.

PMID:
17043836
[PubMed - indexed for MEDLINE]
9.

Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.

Romero A, Sued O, Puig T, Esteve A, Pumarola T, Casabona J, González V, Matas L, Tural C, Rodrigo I, Margall N, Domingo P, Casanova A, Ferrer E, Caballero E, Ribera E, Farré J, Puig T, Amengual MJ, Navarro G, Prat JM, Masabeu A, Simó JM, Villaverde CA, Barrufet P, Sauca MG, Ortin X, Ortí A, Navarro R, Euras JM, Vilaró J, Villà MC, Montull S, Vilanova C, Pujol F, Díaz O, Miró JM; AERI study Group.

Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):482-9. doi: 10.1016/j.eimc.2011.03.001. Epub 2011 May 2.

PMID:
21543135
[PubMed - indexed for MEDLINE]
10.

Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.

Hogg RS, Bangsberg DR, Lima VD, Alexander C, Bonner S, Yip B, Wood E, Dong WW, Montaner JS, Harrigan PR.

PLoS Med. 2006 Sep;3(9):e356.

PMID:
16984218
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failure.

Badri SM, Adeyemi OM, Max BE, Hota BN, Barker DE.

AIDS Patient Care STDS. 2007 Aug;21(8):544-50.

PMID:
17711379
[PubMed - indexed for MEDLINE]
12.

HIV type-1 clade C resistance genotypes in treatment-naive patients and after first virological failure in a large community antiretroviral therapy programme.

Orrell C, Walensky RP, Losina E, Pitt J, Freedberg KA, Wood R.

Antivir Ther. 2009;14(4):523-31.

PMID:
19578237
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Drug-resistance mutations in antiretroviral-naïve patients with established HIV-1 infection in Mexico.

Escoto-Delgadillo M, Vázquez-Valls E, Ramírez-Rodríguez M, Corona-Nakamura A, Amaya-Tapia G, Quintero-Pérez N, Panduro-Cerda A, Torres-Mendoza BM.

HIV Med. 2005 Nov;6(6):403-9.

PMID:
16268822
[PubMed - indexed for MEDLINE]
14.

Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.

Machado ES, Lambert JS, Watson DC, Afonso AO, da Cunha SM, Nogueira SA, Caride E, Oliveira RH, Sill AM, DeVico A, Tanuri A.

J Clin Virol. 2004 May;30(1):24-31.

PMID:
15072750
[PubMed - indexed for MEDLINE]
15.

A genotyping study of human immunodeficiency virus type-1 drug resistance in a small Brazilian municipality.

Eyer-Silva WA, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Dec;100(8):869-73. Epub 2006 Jan 20.

PMID:
16444418
[PubMed - indexed for MEDLINE]
Free Article
16.

Primary resistance of human immunodeficiency virus type 1 in a reference center in Recife, Pernambuco, Brazil.

de Medeiros LB, Lacerda HR, Cavalcanti AM, de Albuquerque Mde F.

Mem Inst Oswaldo Cruz. 2006 Dec;101(8):845-9.

PMID:
17293977
[PubMed - indexed for MEDLINE]
Free Article
17.

Genotypic resistance of antiretroviral drugs among drug-naive HIV type 1 patients with the background of long-term access-easy zidovudine therapy.

Park SW, Kim HB, Choi YJ, Kim NJ, Oh MD, Choe KW.

AIDS Res Hum Retroviruses. 2003 Nov;19(11):1039-43.

PMID:
14686324
[PubMed - indexed for MEDLINE]
18.

The prevalence of resistance-associated mutations to protease and reverse transcriptase inhibitors in treatment-naïve (HIV1)-infected individuals in Casablanca, Morocco.

Bakhouch K, Oulad-Lahcen A, Bensghir R, Blaghen M, Elfilali KM, Ezzikouri S, Abidi O, Hassar M, Wakrim L.

J Infect Dev Ctries. 2009 Jun 1;3(5):380-91.

PMID:
19759509
[PubMed - indexed for MEDLINE]
Free Article
19.

Antiretroviral resistance mutations in human immunodeficiency virus type 1 infected patients enrolled in genotype testing at the Central Public Health Laboratory, São Paulo, Brazil: preliminary results.

Rodrigues R, Vazquez CM, Colares JK, Custodio RM, Bonásser Filho F, Souza Ldo R, Gianna MC, Marques CC, Brígido LF.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):97-102. Epub 2005 Apr 12.

PMID:
15867972
[PubMed - indexed for MEDLINE]
Free Article
20.

Prevalence of resistance mutations in antiretroviral-naive chronically HIV-infected patients in 1998: a French nationwide study.

Descamps D, Calvez V, Izopet J, Buffet-Janvresse C, Schmuck A, Colson P, Ruffault A, Maillard A, Masquelier B, Cottalorda J, Harzic M, Brun-Vézinet F, Costagliola D; ANRS Antiretroviral Resistance Study Group.

AIDS. 2001 Sep 28;15(14):1777-82.

PMID:
11579238
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk